Investigation on the Status Quo of Hyperalgesia in Patients After Thoracoscopic Operation and Study on the Effect of Intraoperative Intervention
Launched by FUJIAN MEDICAL UNIVERSITY UNION HOSPITAL · Jan 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a condition called hyperalgesia, which means experiencing increased pain sensitivity, in patients who have undergone thoracoscopic surgery (a type of minimally invasive surgery on the chest). The study aims to understand how common this condition is after surgery and what factors might influence it. Additionally, researchers are testing whether listening to specific sounds through headphones during surgery can help reduce this heightened pain sensitivity.
To participate in the trial, you should be at least 18 years old and undergoing a specific type of lung cancer surgery performed by a particular group of surgeons. It's important that you can communicate well and follow instructions throughout the study. If you have had previous thoracic surgery, a history of chronic pain, or certain other health issues, you may not be eligible. If you join the trial, you can expect to share your experiences and help researchers learn more about managing pain after surgery, which could benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients selected by the same group of surgeons to perform thoracoscopic three-hole radical resection of lung cancer
- • Patients ≥18 years old, able to communicate effectively and cooperate with the completion of clinical trials
- • ASA grade I-III
- • Normal hearing; Patients who have not participated in other trials in the last two months
- Exclusion Criteria:
- • Previous history of thoracic surgery
- • History of chronic pain and any intake of analgesics 48 hours before surgery; ● Have a history of mental illness, or have taken psychiatric drugs or received psychological treatment in the past six months
- • Deformity of the auricle, inability to wear headphones, and failure to cooperate with this study for any reason
- • suffering from concurrent severe organ system diseases and hearing impairment
- • Incomplete data collection
About Fujian Medical University Union Hospital
Fujian Medical University Union Hospital is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent clinical trial sponsor, the hospital is committed to conducting high-quality studies that contribute to the development of new therapies and medical interventions. With a multidisciplinary team of experienced healthcare professionals and researchers, Fujian Medical University Union Hospital emphasizes ethical standards, patient safety, and scientific rigor in all its clinical trials, fostering collaboration with both local and international research partners to enhance medical knowledge and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fujian, Fuzhou, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported